Leukemia inhibitory factor promotes EMT through STAT3-dependent miR-21 induction

Area of Science:

• Oncology
• Molecular Biology
• Cytokine Signaling

Background:

• Leukemia inhibitory factor (LIF) is a cytokine with diverse functions.
• LIF's role in cancer progression and metastasis is increasingly recognized.
• The precise mechanisms by which LIF influences tumor metastasis remain incompletely understood.

Purpose of the Study:

• To investigate the role of LIF in epithelial-mesenchymal transition (EMT), a critical process in tumor metastasis.
• To elucidate the molecular mechanisms underlying LIF-induced EMT and tumor cell migration.

Main Methods:

• Overexpression and knockdown of LIF in human tumor cells.
• Analysis of epithelial and mesenchymal markers.
• Quantification of microRNA-21 (miR-21) expression.
• Assessment of STAT3 activation.
• Inhibition of miR-21 function to evaluate its role in LIF-mediated effects.

Main Results:

• LIF overexpression promoted EMT, characterized by morphological changes and altered marker expression.
• Knockdown of LIF reversed EMT in cancer cells.
• LIF induced miR-21 expression via STAT3 activation.
• Blocking miR-21 significantly inhibited LIF-induced EMT and cancer cell migration.

Conclusions:

• LIF promotes EMT and tumor metastasis by inducing miR-21 expression through STAT3 activation.
• miR-21 is a critical mediator of LIF's pro-metastatic effects.
• Targeting the LIF-miR-21 axis may offer a novel therapeutic strategy for cancer metastasis.